Proximal Humerus Fracture
Conditions
Interventions
Experimental Group:Liposomal bupivacaine in combination with bupivacaine
Sponsors
Nanjing Pukou District Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age 18 to 75 years old; 2. American Society of Anesthesiologists (ASA) grade I-III; 3. The first open reduction and internal fixation of the proximal humerus fracture; 4. No contraindications to postoperative rehabilitation training.
Exclusion criteria
Exclusion criteria: 1. Patients with a known history of liposomal bupivacaine and bupivacaine allergy; 2. Patients admitted to ICU for monitoring and treatment after surgery; Patients who refuse to undergo rehabilitation training after surgery; 3. Patients with previous long-term oral opioid analgesics, patients who have participated in other drugs or clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain scores at different time points in resting state;Pain scores during rehabilitation exercises at different postoperative time points;Postoperative intravenous analgesia application;Progress of postoperative motor function rehabilitation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication rate of peripheral nerve blocks; | — |
Countries
China
Contacts
Public ContactPengpeng Zhang
Nanjing Pukou District Hospital of Traditional Chinese Medicine
Outcome results
None listed